Related references
Note: Only part of the references are listed.Gene Therapy Through Autologous Transplantation of Gene-Modified Hematopoietic Stem Cells
Donald B. Kohn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome
Nizar Mahlaoui et al.
BLOOD (2013)
Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation
Ulrike Gerdemann et al.
BLOOD (2013)
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
Ashley T. Martino et al.
BLOOD (2013)
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
Ann M. Leen et al.
BLOOD (2013)
Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant
Jenny McIntosh et al.
BLOOD (2013)
A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells
Yu-Hsiang Chang et al.
CANCER RESEARCH (2013)
Combinatorial RNA-based gene therapy for the treatment of HIV/AIDS
Janet Chung et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Chronic Granulomatous Disease
Steven M. Holland
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2013)
Alpharetroviral Vector-mediated Gene Therapy for X-CGD: Functional Correction and Lack of Aberrant Splicing
Kerstin B. Kaufmann et al.
MOLECULAR THERAPY (2013)
Long-Term Follow-up of Foamy Viral Vector-Mediated Gene Therapy for Canine Leukocyte Adhesion Deficiency
Thomas R. Bauer et al.
MOLECULAR THERAPY (2013)
Preclinical Safety and Efficacy of Human CD34(+) Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome
Samantha Scaramuzza et al.
MOLECULAR THERAPY (2013)
Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases
Lijing Li et al.
MOLECULAR THERAPY (2013)
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
James N. Kochenderfer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma
Mariana Puntel et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Thomas Gaj et al.
TRENDS IN BIOTECHNOLOGY (2013)
The Switch from Fetal to Adult Hemoglobin
Vijay G. Sankaran et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Expanding the Repertoire of Target Sites for Zinc Finger Nuclease-mediated Genome Modification
Kimberly A. Wilson et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Phoenix rising: gene therapy makes a comeback
Maria P. Limberis
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2012)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome
Alexander Astrakhan et al.
BLOOD (2012)
The gene therapy journey for hemophilia: are we there yet?
Katherine A. High
BLOOD (2012)
Zinc-finger nuclease-mediated correction of α-thalassemia in iPS cells
Chan-Jung Chang et al.
BLOOD (2012)
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans
Fabio Candotti et al.
BLOOD (2012)
Genetic correction of β-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice
Yixuan Wang et al.
CELL RESEARCH (2012)
Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease
Hans-Peter Kiem et al.
CELL STEM CELL (2012)
Gene Therapy for Severe Combined Immunodeficiency due to Adenosine Deaminase Deficiency
Claudia A. Montiel-Equihua et al.
CURRENT GENE THERAPY (2012)
Gene therapy for primary immunodeficiencies: part 1
Marina Cavazzana-Calvo et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Gene therapy for primary immunodeficiencies: Part 2
Alessandro Aiuti et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
CTF/NF1 transcription factors act as potent genetic insulators for integrating gene transfer vectors
A. Gaussin et al.
GENE THERAPY (2012)
Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency
J. C. M. van der Loo et al.
GENE THERAPY (2012)
Gene Therapy for Primary Immunodeficiencies
Christine Rivat et al.
HUMAN GENE THERAPY (2012)
Gene Therapy for Fanconi Anemia: One Step Closer to the Clinic
Jakub Tolar et al.
HUMAN GENE THERAPY (2012)
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
David F. Stroncek et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Safer, Silencing-Resistant Lentiviral Vectors: Optimization of the Ubiquitous Chromatin-Opening Element through Elimination of Aberrant Splicing
Sean Knight et al.
JOURNAL OF VIROLOGY (2012)
Expansion of Polyfunctional HIV-Specific T Cells upon Stimulation with mRNA Electroporated Dendritic Cells in the Presence of Immunomodulatory Drugs
Brenda De Keersmaecker et al.
JOURNAL OF VIROLOGY (2012)
Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease
Ning Sun et al.
MOLECULAR BIOSYSTEMS (2012)
Challenges in Vector and Trial Design Using Retroviral Vectors for Long-Term Gene Correction in Hematopoietic Stem Cell Gene Therapy
Jacqueline Corrigan-Curay et al.
MOLECULAR THERAPY (2012)
Alpharetroviral Self-inactivating Vectors: Long-term Transgene Expression in Murine Hematopoietic Cells and Low Genotoxicity
Julia D. Suerth et al.
MOLECULAR THERAPY (2012)
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2012)
Gene therapy matures in the clinic
Leonard W. Seymour et al.
NATURE BIOTECHNOLOGY (2012)
Extended Survival of Glioblastoma Patients After Chemoprotective HSC Gene Therapy
Jennifer E. Adair et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
GENE THERAPY FOR CHRONIC GRANULOMATOUS DISEASE
Elizabeth M. Kang et al.
METHODS IN ENZYMOLOGY, VOL 507: GENE TRANSFER VECTORS FOR CLINICAL APPLICATION (2012)
Recombinant adeno-associated virus: clinical application and development as a gene-therapy vector
Ping-Jie Xiao et al.
THERAPEUTIC DELIVERY (2012)
Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer
Andrew Wilber et al.
BLOOD (2011)
Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities
Andrew Wilber et al.
BLOOD (2011)
Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease
Jizhong Zou et al.
BLOOD (2011)
Species D Adenoviruses as Oncolytics against B-cell Cancers
Christopher Y. Chen et al.
CLINICAL CANCER RESEARCH (2011)
Gene therapy for the Wiskott-Aldrich syndrome
Anne Galy et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Genetic correction of X-linked chronic granulomatous disease with novel foamy virus vectors
Ilenia Chatziandreou et al.
EXPERIMENTAL HEMATOLOGY (2011)
Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease
I. Barde et al.
GENE THERAPY (2011)
Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application
Otto-Wilhelm Merten et al.
HUMAN GENE THERAPY (2011)
Gene therapy for leukodystrophies
Alessandra Biffi et al.
HUMAN MOLECULAR GENETICS (2011)
Development of Novel Efficient SIN Vectors with Improved Safety Features for Wiskott-Aldrich Syndrome Stem Cell Based Gene Therapy
Ines Avedillo Diez et al.
MOLECULAR PHARMACEUTICS (2011)
Retroviral Gene Therapy for X-linked Chronic Granulomatous Disease: Results From Phase I/II Trial
Hyoung Jin Kang et al.
MOLECULAR THERAPY (2011)
Insertion Sites in Engrafted Cells Cluster Within a Limited Repertoire of Genomic Areas After Gammaretroviral Vector Gene Therapy
Annette Deichmann et al.
MOLECULAR THERAPY (2011)
Gene Therapy of Chronic Granulomatous Disease: The Engraftment Dilemma
Manuel Grez et al.
MOLECULAR THERAPY (2011)
Biochemical Correction of X-CGD by a Novel Chimeric Promoter Regulating High Levels of Transgene Expression in Myeloid Cells
Giorgia Santilli et al.
MOLECULAR THERAPY (2011)
Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins
Amit C. Nathwani et al.
MOLECULAR THERAPY (2011)
Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells
Eirini P. Papapetrou et al.
NATURE BIOTECHNOLOGY (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
Jian Xu et al.
SCIENCE (2011)
Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction
H. Bobby Gaspar et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges
Deepak Raj et al.
EXPERT REVIEW OF HEMATOLOGY (2011)
A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells
Sheng Zhou et al.
BLOOD (2010)
Progress and prospects: Foamy virus vectors enter a new age
O. Erlwein et al.
GENE THERAPY (2010)
Clinical Impact of Suicide Gene Therapy in Allogeneic Hematopoietic Stem Cell Transplantation
Maria Teresa Lupo-Stanghellini et al.
HUMAN GENE THERAPY (2010)
Self-Inactivating Alpharetroviral Vectors with a Split-Packaging Design
Julia D. Suerth et al.
JOURNAL OF VIROLOGY (2010)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
Stefan Stein et al.
NATURE MEDICINE (2010)
Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
Salima Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Stem-Cell Gene Therapy for the Wiskott-Aldrich Syndrome
Kaan Boztug et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
WASP: a key immunological multitasker
Adrian J. Thrasher et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy
Barbara Cassani et al.
BLOOD (2009)
Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott-Aldrich Syndrome in Preclinical Models
Francesco Marangoni et al.
MOLECULAR THERAPY (2009)
Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors
Ute Modlich et al.
MOLECULAR THERAPY (2009)
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.
Alessandro Aiuti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Elena E. Perez et al.
NATURE BIOTECHNOLOGY (2008)
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Vijay G. Sankaran et al.
SCIENCE (2008)
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery
Angelo Lombardo et al.
NATURE BIOTECHNOLOGY (2007)
Identification and characterization of cell type-specific and ubiquitous chromatin regulatory structures in the human genome
Hualin Xi et al.
PLOS GENETICS (2007)
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
Ann M. Leen et al.
NATURE MEDICINE (2006)
Correction of sickle cell disease by homologous recombination in embryonic stem cells
Li-Chen Wu et al.
BLOOD (2006)
Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation
L Dupré et al.
HUMAN GENE THERAPY (2006)
Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy
C Sevin et al.
HUMAN MOLECULAR GENETICS (2006)
Insulators: exploiting transcriptional and epigenetic mechanisms
Miklos Gaszner et al.
NATURE REVIEWS GENETICS (2006)
Chimeric nucleases stimulate gene targeting in human cells
MH Porteus et al.
SCIENCE (2003)
Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks
MH Porteus et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo
DM McCarty et al.
GENE THERAPY (2003)
Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations
U Matzner et al.
GENE THERAPY (2002)
Share Paper
